CLDX
Celldex Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$39.68
+0.79%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+37.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 29, 2026 | Jain Rita · director | A-Award | 26,000 | $34 |
| Jun 29, 2026 | Cohen Cheryl · director | A-Award | 26,000 | $34 |
| Jun 29, 2026 | PENNER HARRY JR · director | A-Award | 26,000 | $34 |
| Jun 29, 2026 | KELER TIBOR · officer: EXECUTIVE VP & CSO | A-Award | 115,000 | $34 |
| Jun 29, 2026 | Martin Samuel Bates · officer: SVP AND CFO | A-Award | 93,000 | $34 |
| Jun 29, 2026 | Brownlie Keith L · director | A-Award | 26,000 | $34 |
| Jun 29, 2026 | Cavanaugh Sarah · officer: SVP OF CORP AFFAIRS & ADMIN. | A-Award | 95,000 | $34 |
| Jun 29, 2026 | Torres Denice · director | A-Award | 26,000 | $34 |
| Jun 29, 2026 | CONRAD HERBERT J · director | A-Award | 26,000 | $34 |
| Jun 29, 2026 | Jimenez Freddy A. · officer: SVP & GENERAL COUNSEL | A-Award | 93,000 | $34 |
| Jun 29, 2026 | Heath-Chiozzi Margo · officer: SVP OF REGULATORY AFFAIRS | A-Award | 95,000 | $34 |
| Jun 29, 2026 | Marucci Anthony S · director, officer: PRESIDENT & CEO | A-Award | 375,000 | $34 |
| Jun 29, 2026 | Young Diane C. · officer: SVP, CHIEF MEDICAL OFFICER | A-Award | 57,000 | $34 |
| Jun 29, 2026 | Crowley Elizabeth · officer: SR. VP & CPDO | A-Award | 100,000 | $34 |
| Jun 29, 2026 | Lawver Teri L · officer: SVP & Chief Commercial Officer | A-Award | 90,000 | $34 |
| Jun 29, 2026 | PEPIN RONALD · officer: SR. VP & CBO | A-Award | 20,000 | $34 |
| Jun 29, 2026 | NEIL GARRY ARTHUR · director | A-Award | 26,000 | $34 |
| Jun 29, 2026 | MARINO JAMES J · director | A-Award | 26,000 | $34 |
| Jan 6, 2026 | Martin Samuel Bates · officer: SVP AND CFO | M-Exempt | 4,817 | $10 |
| Dec 17, 2025 | PEPIN RONALD · officer: SR. VP & CBO | M-Exempt | 8,333 | $9.02 |
| Dec 17, 2025 | PEPIN RONALD · officer: SR. VP & CBO | M-Exempt | 11,000 | $2.78 |
| Dec 8, 2025 | Jimenez Freddy A. · officer: SVP & GENERAL COUNSEL | Sale | 4,166 | $29 |
| Nov 17, 2025 | Wright Richard M. · other: Former Officer | M-Exempt | 6,876 | $9.02 |
| Nov 17, 2025 | Wright Richard M. · other: Former Officer | M-Exempt | 26,672 | $10 |
| Nov 17, 2025 | Wright Richard M. · other: Former Officer | M-Exempt | 15,750 | $22 |
| Nov 17, 2025 | Wright Richard M. · other: Former Officer | Sale | 49,298 | $24 |
| Nov 12, 2025 | Lawver Teri L · officer: SVP & Chief Commercial Officer | A-Award | 100,000 | $23 |
| Aug 15, 2025 | Jimenez Freddy A. · officer: SVP & GENERAL COUNSEL | Sale | 341 | $24 |
| Aug 15, 2025 | Jimenez Freddy A. · officer: SVP & GENERAL COUNSEL | Sale | 430 | $25 |
| Jun 9, 2025 | Crowley Elizabeth · officer: SR. VP & CPDO | A-Award | 85,000 | $20 |
Institutional positioning
13F filings over the trailing two quarters
New 111Increased 178Reduced 118Sold out 21
| Filer | Action | Shares | Filed |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 9,543,671 | Aug 14, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 8,560,476 | May 15, 2026 |
| BlackRock, Inc. | Increased | 7,002,530 | Aug 7, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Reduced | 5,840,567 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 5,369,885 | May 13, 2026 |
| Kynam Capital Management, LP | Reduced | 5,322,908 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 4,685,223 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 3,900,427 | Aug 7, 2026 |
| FMR LLC | Reduced | 3,749,048 | May 15, 2026 |
| FMR LLC | Reduced | 3,722,888 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,464,831 | Aug 13, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 3,229,939 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,960,895 | May 15, 2026 |
| Deep Track Capital, LP | Increased | 2,939,151 | Aug 14, 2026 |
| STATE STREET CORP | Reduced | 2,804,168 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 29, 2026